Last $4.57 USD
Change Today +0.06 / 1.33%
Volume 52.2K
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for enzo biochem inc (ENZ)

This company's debt to total capital ratio, at 10.02%, is in-line with the Life Sciences Tools and Services industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are among the industry's worst with 47.09 days worth of sales outstanding. This implies that revenues are not being collected in an efficient manner. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 58.83 days.
Currency in
Millions of US Dollars
As of:Jul 31
2011
Jul 31
2012
Jul 31
2013
Jul 31
2014
4 Year
Trend
Assets    
Cash and Equivalents14.215.19.017.5
Short-Term Investments10.0------
TOTAL CASH AND SHORT TERM INVESTMENTS24.215.19.017.5
Accounts Receivable15.214.112.312.5
TOTAL RECEIVABLES15.214.112.312.5
Inventory9.38.88.88.7
Prepaid Expenses2.72.42.52.1
TOTAL CURRENT ASSETS51.440.432.640.7
Gross Property Plant and Equipment31.231.633.534.3
Accumulated Depreciation-20.9-22.5-24.9-26.6
NET PROPERTY PLANT AND EQUIPMENT10.39.18.67.7
Goodwill27.47.57.57.5
Other Intangibles20.011.89.98.1
Other Long-Term Assets0.40.40.40.4
TOTAL ASSETS109.569.159.064.4
    
LIABILITIES & EQUITY    
Accounts Payable7.99.08.58.2
Accrued Expenses8.29.811.812.9
Short-Term Borrowings----3.33.0
Current Portion of Long-Term Debt/Capital Lease--0.10.30.4
Current Portion of Capital Lease Obligations----0.10.1
Other Current Liabilities, Total1.3----0.4
Unearned Revenue, Current0.4------
TOTAL CURRENT LIABILITIES17.719.023.925.0
Long-Term Debt0.10.10.30.4
Capital Leases----0.50.3
Deferred Tax Liability Non-Current2.90.90.20.2
Other Non-Current Liabilities------1.6
TOTAL LIABILITIES20.820.024.827.5
Common Stock0.40.40.40.4
Additional Paid in Capital305.8304.4304.3317.2
Retained Earnings-214.9-254.2-272.4-282.4
Treasury Stock-6.4-3.1----
Comprehensive Income and Other3.81.61.91.7
TOTAL COMMON EQUITY88.749.134.137.0
TOTAL EQUITY88.749.134.137.0
TOTAL LIABILITIES AND EQUITY109.569.159.064.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $4.57 USD +0.06

ENZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Merge Healthcare Inc $3.63 USD +0.04
NanoString Technologies Inc $14.48 USD +0.55
Pacific Biosciences of California Inc $7.83 USD +0.37
Sequenom Inc $3.73 USD +0.14
WaferGen Bio-systems Inc $3.23 USD -0.07
View Industry Companies
 

Industry Analysis

ENZ

Industry Average

Valuation ENZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.1x
Price/Book 5.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.